Filing Details
- Accession Number:
- 0001209191-20-050079
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-10 20:49:16
- Reporting Period:
- 2020-09-08
- Accepted Time:
- 2020-09-10 20:49:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1322505 | Albireo Pharma Inc. | ALBO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1687436 | Jan Mattsson | C/O Albireo Pharma Inc. 10 Post Office Square, Suite 1000 Boston MA 02109 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-09-08 | 10,000 | $45.55 | 24,214 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2020.